Pathogenesis of gastroesophageal reflux and Barrett esophagus

Mayo Clinic Proceedings

Volumn 76, Issue 2, 2001, Pages 226-234

  Buttar, Navtej S ^a   Falk, Gary W ^b  

^a MAYO CLINIC   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; BARRETT ESOPHAGUS; BILE REFLUX; CIGARETTE SMOKING; CONFERENCE PAPER; CONTROLLED STUDY; GASTROESOPHAGEAL REFLUX; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HIATUS HERNIA; HUMAN; LOWER ESOPHAGUS SPHINCTER; NONHUMAN; PATHOGENESIS; REFLUX ESOPHAGITIS; STOMACH ACID SECRETION;

EID: 0035146841     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-6196(11)63134-0     Document Type: Conference Paper

References (88)

1. Liebermann-Meffert D, Allgower M, Schmid P, Blum AL. Muscular equivalent of the lower esophageal sphincter. Gastroenterology. 1979;76:31-38.
2. Mittal RK, Balaban DH. The esophagogastric junction. N Engl J Med. 1997:336:924-932.
3. Seelig LL Jr, Goyal RK. Morphological evaluation of opossum lower esophageal sphincter. Gastroenterology. 1978;75:51-58.
4. Christensen J, Roberts RL. Differences between esophageal body and lower esophageal sphincter in mitochondria of smooth muscle in opossum. Gastroenterology. 1983;85:650-656.
5. Christensen J, Conklin JL, Freeman BW. Physiologic specialization at esophagogastric junction in three species. Am J Physiol. 1973;225:1265-1270.
6. Goyal RK, Rattan S. Genesis of basal sphincter pressure: effect of tetrodotoxin on lower esophageal sphincter pressure in opossum in vivo. Gastroenterology. 1976;71:62-67.
7. DiMarino AJ, Cohen S. The adrenergic control of lower esophageal sphincter function: an experimental model of denervation supersensitivity. / Clin Invest. 1973;52:2264-2271.
8. Fournet J, Snape WJ Jr, Cohen S. Sympathetic control of lower esophageal sphincter function in the cat: action of direct cervical and splanchnic nerve stimulation. J Clin Invest. 1979;63:562-570.
9. Kawahara H, Blackshaw LA, Lehmann A, Dent J. Responses of the rat lower oesophageal sphincter (LOS) to vagal efferent activation. Neurogastroenterol Motil. 1997;9:85-97.
10. Paterson WG, Andersen MA, Anand N. Pharmacological characterization of lower esophageal sphincter relaxation induced by swallowing, vagal efferent nerve stimulation, and esophageal distention. Can JPhysiol Pharmacol. 1992;70:1011-1015.
11. Blackshaw LA, Haupt JA, Omari T, Dent J. Vagal and sympathetic influences on the ferret lower oesophageal sphincter. J Auton Nerv Syst. 1997;66:179-188.
12. Murray J, Du C, Ledlow A, Bates JN, Conklin JL. Nitric oxide: mediator of nonadrenergic noncholinergic responses of opossum esophageal muscle. Am J Physiol. 1991;261(3, pt 1):G401G406.
13. Murray JA, Ledlow A, Launspach J, Evans D, Loveday M, Conklin JL. The effects of recombinant human hemoglobin on esophageal motor functions in humans. Gastroenterology. 1995; 109:12411248.
14. Dodds WJ, Dent J, Hogan WJ, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med. 1982;307:1547-1552.
15. Mittal RK, McCallum RW. Characteristics and frequency of transient relaxations of the lower esophageal sphincter in patients with reflux esophagitis. Gastroenterology. 1988;95:593-599.
16. Dent J, Holloway RH, Toouli J, Dodds WJ. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux. Gut. 1988;29:1020-1028.
17. Mittal RK, Holloway RH, Penagini R, Blackshaw LA, Dent J. Transient lower esophageal sphincter relaxation. Gastroenterology. 1995; 109:601-610.
18. Kahrilas PJ, Shi G, Manka M, Joehl RJ. Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia. Gastroenterology. 2000; 118:688-695.
19. Holloway RH, Hongo M, Berger K, McCallum RW. Gastric distention: a mechanism for postprandial gastroesophageal reflux. Gastroenterology. 1985;89:779-784.
20. Schoeman MN, Tippett MD, Akkermans LM, Dent J, Holloway RH. Mechanisms of gastroesophageal reflux in ambulant healthy human subjects. Gastroenterology. 1995; 108:83-91.
21. Sloan S, Rademaker AW, Kahrilas PJ. Determinants of gastroesophageal junction incompetence: hiatal hernia, lower esophageal sphincter, or both? Ann Intern Med. 1992; 117:977-982.
22. Cadiot G, Bruhat A, Rigaud D, et al. Multivariate analysis of pathophysiological factors in reflux oesophagitis. Gut. 1997;40: 167-174.
23. Kahrilas PJ. Anatomy and physiology of the gastroesophageal junction. Gastroenterol Clin North Am. 1997;26:467-486.
24. Moss SF, Arnold R, Tytgat GN, et al. Consensus Statement for Management of Gastroesophageal Reflux Disease: result of workshop meeting at Yale University School of Medicine, Department of Surgery, November 16 and 17, \991.JClinGastroenterol. 1998; 27:6-12.
25. Mittal RK. Hiatal hernia: myth or reality? Am J Med. 1997;103: 33S-39S.
26. Mittal RK, Lange RC, McCallum RW. Identification and mechanism of delayed esophageal acid clearance in subjects with hiatus hernia. Gastroenterology. 1987;92:130-135.
27. Sloan S, Kahrilas PJ. Impairment of esophageal emptying with hiatal hernia. Gastroenterology. 1991; 100:596-605.
28. Kahrilas PJ, Wu S, Lin S, Pouderoux P. Attenuation of esophageal shortening during peristalsis with hiatus hernia. Gastroenterology. 1995;109:1818-1825.
29. Vaezi MF, Singh S, Richter JE. Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology. 1995;108:1897-1907.
30. Vaezi MF, Richter JE. Synergism of acid and duodenogastroesophageal reflux in complicated Barren's esophagus. Surgery. 1995; 117:699-704.
31. Champion G, Richter JE, Vaezi MF, Singh S, Alexander R. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology. 1994;107:747754.
32. Hirschowitz BI. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology. 1991;101:1149-1158.
33. Miller LS, Vinayek R, Frucht H, Gardner JD, Jensen RT, Maton PN. Reflux esophagitis in patients with Zollinger-Ellison syndrome. Gastroenterology. 1990;98:341-346.
34. Collen MJ, Johnson DA, Sheridan MJ. Basal acid output and gastric acid hypersécrétion in gastroesophageal reflux disease: correlation with ranitidine therapy. Dig Dis Sei. 1994;39:410417.
35. Collen MJ, Lewis JH, Benjamin SB. Gastric acid hypersécrétion in refractory gastroesophageal reflux disease. Gastroenterology. 1990;98:654-661.
36. McCallum RW, Berkowitz DM, Lerner E. Gastric emptying in patients with gastroesophageal reflux. Gastroenterology. 1981;80: 285-291.
37. Maddern GJ, Chatterton BE, Collins PJ, Horowitz M, Shearman DJ, Jamieson GG. Solid and liquid gastric emptying in patients with gastro-oesophageal reflux. BrJSurg. 1985;72:344-347.
38. Shay SS, Eggli D, McDonald C, Johnson LF. Gastric emptying of solid food in patients with gastroesophageal reflux. Gastroenterology. 1987;92:459-465.
39. Keshavarzian A, Bushnell DL, Sontag S, Yegelwel EJ, Smid K. Gastric emptying in patients with severe reflux esophagitis. Am J Gastroenterol. 1991;86:738-742.
40. Helm JF, Dodds WJ, Pelc LR, Palmer DW, Hogan WJ, Teeter BC. Effect of esophageal emptying and saliva on clearance of acid from the esophagus. W Engl J Med. 1984;310:284-288.
41. Kahrilas PJ, Dodds WJ, Hogan WJ, Kern M, Arndorfer RC, Reece A. Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology. 1986;91:897-904.
42. Eastwood GL, Castell DO, Higgs RH. Experimental esophagitis in cats impairs lower esophageal sphincter pressure. Gastroenterology. 1975;69:146-153.
43. Eckardt VF. Does healing of esophagitis improve esophageal motor function? Dig Dis Sei. 1988;33:161-165.
44. Howard JM, Reynolds RP, Frei JV, et al. Macroscopic healing of esophagitis does not improve esophageal motility. Dig Dis Sei. 1994;39:648-654.
45. Kongara KR, Soffer EE. Saliva and esophageal protection. Am J Gastroenterol. 1999;94:1446-1452.
46. Orlando RC. Mechanisms of reflux-induced epithelial injuries in the esophagus. Am J Med. 2000; 108(suppl 4a):104S-108S.
47. Vitale GC, Cheadle WG, Patel B, Sadek SA, Michel ME, Cuschieri A. The effect of alcohol on nocturnal gastroesophageal reflux. JAMA. 1987;258:2077-2079.
48. Nebel OT, Fernes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis. 1976;21 : 953-956.
49. Mayer EM, Grabowski CJ, Fisher RS. Effects of graded doses of alcohol upon esophageal motor function. Gastroenterology. 1978; 75:1133-1136.
50. Schindlbeck NE, Heinrich C, Dendorfer A, Pace F, Muller-Lissner SA. Influence of smoking and esophageal intubation on esophageal pH-metry. Gastroenterology. 1987;92:1994-1997.
51. Waring JP, Eastwood TF, Austin JM, Sanowski RA. The immediate effects of cessation of cigarette smoking on gastroesophageal reflux. Am J Gastroenterol. 1989;84:1076-1078.
52. Kadakia SC, Kikendall JW, Maydonovitch C, Johnson LF. Effect of cigarette smoking on gastroesophageal reflux measured by 24-h ambulatory esophageal pH monitoring. Am J Gastroenterol. 1995;90:1785-1790.
53. Kahrilas PJ, Gupta RR. Mechanisms of acid reflux associated with cigarette smoking. Gut. 1990;31:4-10.
54. Pehl C, Pfeiffer A, Wendl B, Nagy I, Kaess H. Effect of smoking on the results of esophageal pH measurement in clinical routine. J Clin Gastroenterol. 1997;25:503-506.
55. Spechler SJ, Goyal RK. Barren's esophagus. AT Engl J Med. 1986:315:362-371.
56. Bremner CG, Lynch VP, Ellis FH Jr. Barren's esophagus: congenital or acquired? an experimental study of esophageal mucosal regeneration in the dog. Surgery. 1970;68:209-216.
57. Li H, Walsh TN, O'Dowd G, Gillen P, Byrne PJ, Hennessy TP. Mechanisms of columnar metaplasia and squamous regeneration in experimental Barrett's esophagus. Surgery. 1994;! 15:176-181.
58. Gillen P, Keeling P, Byrne PJ, West AB, Hennessy TP. Experimental columnar metaplasia in the canine oesophagus. Br J Surg. 1988;75:113-115.
59. Coenraad M, Masclee AA, Straathof JW, Ganesh S, Griffioen G, Lamers CB. Is Barrett's esophagus characterized by more pronounced acid reflux than severe esophagitis? Am J Gastroenterol. 1998;93:1068-1072.
60. lascone C, DeMeester TR, Little AG, Skinner DB. Barrett's esophagus: functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg. 1983;! 18:543-549.
61. Neumann CS, Cooper BT. 24 hour ambulatory oesophageal pH monitoring in uncomplicated Barrett's oesophagus. Gut. 1994;35: 1352-1355.
62. Singh P, Taylor RH, Colin-Jones DG. Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present. Am J Gastroenterol. 1994;89:349-356.
63. Oberg S, DeMeester TR, Peters JH, et al. The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg. 1999; 117:572-580.
64. Cameron AJ. Barrett's esophagus: prevalence and size of hiatal hernia. Am J Gastroenterol. 1999;94:2054-2059.
65. Mulholland MW, Reid BJ, Levine DS, Rubin CE. Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium. Dig Dis Sei. 1989;34:1329-1334.
66. Collen MJ, Johnson DA. Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus. Dig Dis Sei. 1992;37:570-576.
67. Hirschowitz BI. Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls. Dig Dis Sei. 1996; 41:1384-1391.
68. Savarino V, Mêla GS, Zentilin P, et al. Time pattern of gastric acidity in Barrett's esophagus. Dig Dis Sei. 1996;41:1379-1383.
69. Johnson DA, Winters C, Spurling TJ, Chobanian SJ, Cattau EL Jr. Esophageal acid sensitivity in Barrett's esophagus. J Clin Gastroenterol. 1987;9:23-27.
70. Grade A, Pulliam G, Johnson C, Garewal H, Sampliner RE, Pass R. Reduced chemoreceptor sensitivity in patients with Barrett's esophagus may be related to age and not to the presence of Barrett's epithelium. Am J Gastroenterol. 1997;92:2040-2043.
71. Brandt LJ, Kauvar DR. Laser-induced transient regression of Barrett's epithelium. Gastrointest Endosc. 1992;38:619-622.
72. Van Laethem JL, Cremer M, Peny MO, Delhaye M, Deviere J. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut. 1998; 43:747-751.
73. Haag S, Nandurkar S, Talley NJ. Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods. Gastrointest Endosc. 1999;50:229-240.
74. Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology. 1996;! 11:1192-1199.
75. Gillen P, Keeling P, Byrne PJ, Healy M, O'Moore RR, Hennessy TP. Implication of duodenogastric reflux in the pathogenesis of Barrett's oesophagus. BrJSurg. 1988;75:540-543.
76. Attwood SE, DeMeester TR, Bremner CG, Barlow AP, Hinder R A. Alkaline gastroesophageal reflux: implications in the development of complications in Barrett's columnar-lined lower esophagus. Surgery. 1989;106:764-770.
77. Shields HM, Zwas F, Antonioli DA, Doos WG, Kim S, Spechler SJ. Detection by scanning electron microscopy of a distinctive esophageal surface cell at the junction of squamous and Barrett's epithelium. Dig Dis Sei. 1993;38:97-108.
78. Boch JA, Shields HM, Antonioli DA, Zwas F, Sawhney RA, Trier JS. Distribution of cytokeratin markers in Barrett's specialized columnar epithelium. Gastroenterology. 1997;! 12:760765.
79. O'Connor HJ. Review article: Helicobacter pylori and gastrooesophageal reflux disease-clinical implications and management. Aliment Pharmacol Ther. 1999;13:117-127.
80. O'Connor JB, Falk GW, Richter JE. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol. 1999;94: 2037-2042.
81. El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut. 1998;43:327-333.
82. Banatvala N, Mayo K, Megraud F, Jennings R, Decks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis. 1993; 168:219-221.
83. Varanasi RV, Fantry GT, Wilson KT. Decreased prevalence of Helicobacter pylori infection in gastroesophageal reflux disease. Helicobacter. 1998;3:188-194.
84. Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagApositive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology. 1998;! 15:50-57.
85. Werdmuller BF, Loffeld RJ. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sei. 1997; 42:103-105.
86. El-Serag HB, Sonnenberg A, Jamal MM, Inadomi JM, Crooks LA, Feddersen RM. Corpus gastritis is protective against reflux oesophagitis. Gut. 1999;45:181-185.
87. Chow WH, Blaser MJ, Blot WJ, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 1998;58:588-590.
88. Richter JE, Falk GW, Vaezi MF. Helicobacter pylori and gastroesophageal reflux disease: the bug may not be all bad. Am J Gastroenterol. 1998;93:1800-1802.